162 related articles for article (PubMed ID: 33397211)
1. Inspiration and Exasperation: The Challenges of Inhaled Biologics.
Hall P; Vahle JL; Colman K
Toxicol Pathol; 2021 Feb; 49(2):232-234. PubMed ID: 33397211
[TBL] [Abstract][Full Text] [Related]
2. BSTP Review of 12 Case Studies Discussing the Challenges, Pathology, Immunogenicity, and Mechanisms of Inhaled Biologics.
Hall AP; Tepper JS; Boyle MH; Cary MG; Flandre TG; Piaia A; Tarnow I; Macri NP; Freke MC; Nikula KJ; Paul GR; Cauvin A; Gregori M; Haworth R; Naylor S; Price M; Robinson IN; Allen A; Gelzleichter T; Hohlbaum AM; Manetz S; Wolfreys A; Colman K; Fleurance R; Jones D; Mukaratirwa S
Toxicol Pathol; 2021 Feb; 49(2):235-260. PubMed ID: 33455525
[TBL] [Abstract][Full Text] [Related]
3. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
4. Future prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera.
Al-Tabakha MM
J Control Release; 2015 Oct; 215():25-38. PubMed ID: 26222134
[TBL] [Abstract][Full Text] [Related]
5. Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals-The Outcome of a Cross-Industry Working Group Survey.
Wolfreys A; Kilgour J; Allen AD; Dudal S; Freke M; Jones D; Karantabias G; Krantz C; Moore S; Mukaratirwa S; Price M; Tepper J; Cauvin A; Manetz S; Robinson I
Toxicol Pathol; 2021 Feb; 49(2):261-285. PubMed ID: 33535023
[TBL] [Abstract][Full Text] [Related]
6. Inhaled Biologics: From Preclinical to Product Approval.
Fathe K; Ferrati S; Moraga-Espinoza D; Yazdi A; Smyth HD
Curr Pharm Des; 2016; 22(17):2501-21. PubMed ID: 26861725
[TBL] [Abstract][Full Text] [Related]
7. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
[TBL] [Abstract][Full Text] [Related]
8. Inhalation delivery of complex drugs-the next steps.
de Kruijf W; Ehrhardt C
Curr Opin Pharmacol; 2017 Oct; 36():52-57. PubMed ID: 28846876
[TBL] [Abstract][Full Text] [Related]
9. Delivery of biotherapeutics by inhalation aerosol.
Niven RW
Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):151-231. PubMed ID: 9501969
[TBL] [Abstract][Full Text] [Related]
10. Inhaled insulin--does it become reality?
Siekmeier R; Scheuch G
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
[TBL] [Abstract][Full Text] [Related]
11. Newer devices and improved formulations of inhaled insulin.
Rashid J; Absar S; Nahar K; Gupta N; Ahsan F
Expert Opin Drug Deliv; 2015 Jun; 12(6):917-28. PubMed ID: 25485886
[TBL] [Abstract][Full Text] [Related]
12. Inhaled mannitol for cystic fibrosis.
Nolan SJ; Thornton J; Murray CS; Dwyer T
Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of biotherapeutics through the lung: opportunities and challenges for improved lung absorption.
Sakagami M
Ther Deliv; 2013 Dec; 4(12):1511-25. PubMed ID: 24304249
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on Lung Dose and Inhaled Biomolecules.
Wolff RK
Toxicol Pathol; 2021 Feb; 49(2):378-385. PubMed ID: 32851939
[TBL] [Abstract][Full Text] [Related]
15. Oral inhalation for delivery of proteins and peptides to the lungs.
Fröhlich E; Salar-Behzadi S
Eur J Pharm Biopharm; 2021 Jun; 163():198-211. PubMed ID: 33852968
[TBL] [Abstract][Full Text] [Related]
16. Inhaled insulin: a breath of fresh air? A review of inhaled insulin.
Santos Cavaiola T; Edelman S
Clin Ther; 2014 Aug; 36(8):1275-89. PubMed ID: 25044021
[TBL] [Abstract][Full Text] [Related]
17. Technosphere insulin: an inhaled prandial insulin product.
Neumiller JJ; Campbell RK
BioDrugs; 2010 Jun; 24(3):165-72. PubMed ID: 20462282
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change.
VanDevanter DR; Craib ML; Pasta DJ; Millar SJ; Morgan WJ; Konstan MW;
Pediatr Pulmonol; 2018 Jan; 53(1):43-49. PubMed ID: 29064184
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic determinants of biotherapeutics absorption following SC administration.
Richter WF; Bhansali SG; Morris ME
AAPS J; 2012 Sep; 14(3):559-70. PubMed ID: 22619041
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications.
Kuriakose A; Chirmule N; Nair P
J Immunol Res; 2016; 2016():1298473. PubMed ID: 27437405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
